Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 1 February 2026
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 1 February 2026. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Cont. News of ORIONPHARM): Consolidated NAV per share without revaluation surplus was Tk. 78.00 as on December 31, 2025 and Tk. 78.34 as on June 30, 2025. (end)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
(ORIONPHARM-এর চলমান সংবাদ): ৩১ ডিসেম্বর, ২০২৫ তারিখে পুনর্মূল্যায়ন উদ্বৃত্ত ছাড়া শেয়ার প্রতি একত্রিত NAV ছিল ৭৮.০০ টাকা এবং ৩০ জুন, ২০২৫ তারিখে ৭৮.৩৪ টাকা। (শেষ)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 697ecde0b322cf5e51098437
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.